Originally Published in Forbes
On behalf of the Alliance for Transparent & Affordable Prescriptions (ATAP), Dr. Angus Worthing, rheumatologist, suggested that the two bills represent the "tip of an iceberg" as they "raise the larger issue of transparency and disclosure regarding rebates and the various fees generated in the system." Dr. Worthing added that the federal government, through publication of the Department of Health and Human Services (HHS) Blueprint, is building on what states have already put in place.